Chugin Financial Group,Inc. (TYO:5832)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,341,858	1,203,294	1,418,224	1,510,394	1,757,165	1,000,773
Investment Securities	2,928,637	2,796,181	2,620,208	2,346,382	2,526,254	2,639,524
Trading Asset Securities	498	510	1,017	2,023	2,834	1,148
Total Investments	2,929,135	2,796,691	2,621,225	2,348,405	2,529,088	2,640,672
Gross Loans	6,704,381	6,765,240	6,423,480	5,734,702	5,705,571	5,261,313
Allowance for Loan Losses	-72,169	-72,674	-60,570	-54,302	-52,172	-46,291
Net Loans	6,632,212	6,692,566	6,362,910	5,680,400	5,653,399	5,215,022
Property, Plant & Equipment	42,616	42,315	35,622	35,631	36,855	38,766
Other Intangible Assets	2,562	2,523	2,301	1,712	1,484	2,437
Restricted Cash	17,014	11,700	32,000	24,600	27,600	27,300
Other Current Assets	70,970	80,976	48,528	45,852	37,200	40,364
Long-Term Deferred Tax Assets	19,281	28,534	4,582	17,594	827	809
Other Long-Term Assets	180,685	186,977	238,412	185,090	164,591	187,019
Total Assets	11,236,333	11,045,576	10,763,804	9,849,678	10,208,209	9,153,162
Accrued Expenses	1	1,822	1,617	1,572	1,504	1,359
Interest Bearing Deposits	8,538,970	8,363,790	8,309,571	8,053,522	7,861,673	7,667,019
Total Deposits	8,538,970	8,363,790	8,309,571	8,053,522	7,861,673	7,667,019
Short-Term Borrowings	288,726	315,194	303,045	320,430	356,732	255,161
Other Current Liabilities	53,679	55,491	34,450	31,110	30,918	32,031
Long-Term Debt	1,602,407	1,571,308	1,368,143	762,769	1,279,424	473,798
Pension & Post-Retirement Benefits	1,560	1,678	483	3,515	1,850	6,691
Long-Term Deferred Tax Liabilities	509	255	918	423	813	10,354
Other Long-Term Liabilities	184,362	193,674	164,463	148,443	122,881	144,553
Total Liabilities	10,670,214	10,503,212	10,182,690	9,321,784	9,655,795	8,590,966
Common Stock	16,000	16,000	16,000	16,000	15,149	15,149
Additional Paid-In Capital	7,427	7,314	7,292	7,302	8,153	8,153
Retained Earnings	515,392	511,855	494,988	479,223	476,938	463,305
Treasury Stock	-8,245	-7,637	-2,812	-1,000	-11,623	-9,622
Comprehensive Income & Other	35,545	14,832	65,646	26,369	63,797	85,211
Total Common Equity	566,119	542,364	581,114	527,894	552,414	562,196
Shareholders' Equity	566,119	542,364	581,114	527,894	552,414	562,196
Total Liabilities & Equity	11,236,333	11,045,576	10,763,804	9,849,678	10,208,209	9,153,162
Total Debt	1,891,133	1,886,502	1,671,188	1,083,199	1,636,156	728,959
Net Cash (Debt)	-548,777	-682,698	-251,947	429,218	123,843	272,962
Net Cash Growth	-	-	-	246.58%	-54.63%	2093.70%
Net Cash Per Share	-3061.32	-3794.12	-1377.03	2322.55	662.57	1449.96
Filing Date Shares Outstanding	178.66	178.91	181.42	183.7	185.4	187.78
Total Common Shares Outstanding	178.66	178.91	181.96	183.7	185.75	188.06
Book Value Per Share	3168.63	3031.47	3193.61	2873.68	2973.95	2989.47
Tangible Book Value	563,557	539,841	578,813	526,182	550,930	559,759
Tangible Book Value Per Share	3154.29	3017.37	3180.96	2864.36	2965.96	2976.51

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.